A Randomized, Controlled Safety, and Immunogenicity Trial of the M72/AS01 Candidate Tuberculosis Vaccine in HIV-Positive Indian Adults.
about
Novel vaccination approaches to prevent tuberculosis in childrenDifferent Adjuvants Induce Common Innate Pathways That Are Associated with Enhanced Adaptive Responses against a Model Antigen in Humans.Polyfunctional CD4+ T Cells As Targets for Tuberculosis VaccinationAdjuvant-Associated Peripheral Blood mRNA Profiles and Kinetics Induced by the Adjuvanted Recombinant Protein Candidate Tuberculosis Vaccine M72/AS01 in Bacillus Calmette-Guérin-Vaccinated Adults.Phase 2b Controlled Trial of M72/AS01 Vaccine to Prevent Tuberculosis
P2860
A Randomized, Controlled Safety, and Immunogenicity Trial of the M72/AS01 Candidate Tuberculosis Vaccine in HIV-Positive Indian Adults.
description
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
name
A Randomized, Controlled Safet ...... in HIV-Positive Indian Adults.
@en
A Randomized, Controlled Safet ...... in HIV-Positive Indian Adults.
@nl
type
label
A Randomized, Controlled Safet ...... in HIV-Positive Indian Adults.
@en
A Randomized, Controlled Safet ...... in HIV-Positive Indian Adults.
@nl
prefLabel
A Randomized, Controlled Safet ...... in HIV-Positive Indian Adults.
@en
A Randomized, Controlled Safet ...... in HIV-Positive Indian Adults.
@nl
P2093
P2860
P1433
P1476
A Randomized, Controlled Safet ...... in HIV-Positive Indian Adults.
@en
P2093
Anne Bollaerts
Erik Jongert
Faith Esther Beulah
Leo Njock Ayuk
Marie-Ange Demoitié
Opokua Ofori-Anyinam
Philippe Moris
Selvamuthu Poongulali
P2860
P356
10.1097/MD.0000000000002459
P407
P577
2016-01-01T00:00:00Z